Finance

Chromos announces year-end results for 2001

Published in Gene Therapy Weekly, June 13th, 2002

Chromos Molecular Systems, Inc., (CHROMOS; CHR), a global leader in the development and commercialization of chromosome-based technologies, announced its financial results for the fiscal year ended December 31, 2001.

The most significant event that influenced the company's operations during 2001 was the launching of its proprietary ACE System, a chromosome-based vehicle for carrying genes into cells for subsequent expression of proteins.

"Development of The ACE System is pivotal to executing a focused business strategy for 2002," said Alistair Duncan, president and CEO of Chromos. We are now able to build on this milestone achievement by marketing...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2002-06-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry